Condition: T-ALL · Sponsor: Goethe University
The planned trial offers treatment cohorts for patients with full cytologic relapse (R/R ALL - Cohort 1), as well as for patients with molecular failure/relapse (MRD+ ALL - Cohort 2). Basically, the study aims to develop data for optimization of first-line therapy of T-ALL, either by modification of standard induction with Isatuximab or by establishing a post-induction therapy for eradication of MRD and thereby evaluates in parallel two different strategies.
This description comes directly from the study's public registry record.
Nicola Goekbuget, MD · 0049-6963016365 · goekbuget@em.uni-frankfurt.de
Always discuss trial participation with your own doctor first.
| University Hospital Augsburg, II. Medizinischen Klinik, Hämatologie, internistische Onkologie und Hämostaseologie | Augsburg, Germany | Recruiting |
| Charité Berlin, Campus Benjamin Franklin, Department of Hematology, Oncology and Tumorimmunologyt Hämatologie | Berlin, Germany | Recruiting |
| Gesundheit Nord Klinikverbund Bremen gGmbH, Klinikum Bremen-Mitte, Med. Klinik I | Bremen, Germany | Recruiting |
| Klinikum Carl Gustav Carus Dresden, Medizinische Klinik und Poliklinik I | Dresden, Germany | Recruiting |
| University Hospital Düsseldorf, Department of Hematology, Oncology and Clinical Immunology | Düsseldorf, Germany | Recruiting |
| University Hospital Erlangen AöR, Department of Medicine 5 | Erlangen, Germany | Recruiting |
| Goethe University Hospital Frankfurt, Department of Medicine, Hematology and Oncology | Frankfurt am Main, Germany | Recruiting |
| University Hospital Hamburg-Eppendorf, Department of Medicine II | Hamburg, Germany | Recruiting |
| University Hospital Heidelberg, Department V, Hematology, Oncology and Rheumatology | Heidelberg, Germany | Recruiting |
| University Hospital Schleswig-Holstein, Campus Kiel, Medical Department II | Kiel, Germany | Recruiting |
| University Hospital Leipzig; Klinik für Hämatologie, Zelltherapie, Hämostaseologie und Infektiologie, Bereich Hämatologie und Zelltherapie | Leipzig, Germany | Recruiting |
| University Hospital München-Großhadern, Medizinische Klinik und Poliklinik III | München, Germany | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06648889